The National Organization for the Reform of Marijuana Laws (NORML) is proud to endorse Oklahoma’s State Question 788 – a statewide ballot measure that provides patients regulated access to medical cannabis. SQ 788 is a patient-centric plan that empowers physicians to use their discretion when determining their patient’s ideal health care plan.
Oklahomans will go to vote on the measure on June 26.
“We’re excited to offer NORML’s support to the Vote Yes On 788 campaign,” said NORML Outreach Director Kevin Mahmalji. “Together, we will build a broad-based coalition to ensure that lawmakers do not unduly interfere with the bonafide doctor-patient relationship, and that patients are no longer subject to arrest for accessing or growing this important medicine.”
State Question 788 also establishes a licensed system of medical cannabis distribution.
“State Question 788 was designed to make Oklahoma the most patient-oriented and business friendly state for medical marijuana in the country. SQ 788 will create jobs, sorely needed tax revenue, and possesses a number of patient protections that simply don’t exist in other states with similar laws,” said William Jones, campaign manager for the Vote Yes On 788 campaign.
Under the plan, licensed medical marijuana patients may cultivate up to six mature plants, and may possess personal use quantities of marijuana flower, edibles, or infused concentrates. Statewide polling data finds that over 70 percent of residents endorse patients’ access to medical marijuana.
“Recent nationwide polling shows 94 percent of US adults expressed their support for the legalization of medical marijuana, similarly the vast majority of Oklahomans are ready for a new direction. Regardless of the increasing hostility towards marijuana from Attorney General Jeff Sessions, voters in Oklahoma and throughout the country will continue to support common sense cannabis law reforms over the failed policies of prohibition,” said NORML Outreach Director Kevin Mahmalji.
Between now and June 26, representatives with the Vote Yes On 788 campaign will be traveling statewide and meeting face-to-face with voters. NORML will also be focusing its resources in the coming months to support these campaign efforts.
You can visit the campaigns website at http://yeson788.com/ and to follow the Yes on 788 campaign on Facebook here and on Twitter here. Additionally you can contact William Jones with the Yes on 788 campaign at firstname.lastname@example.org.
More details on SQ 788:
Licenses would cost $100 and expire after two years. Those that are recipients of Medicaid, Medicare, or SoonerCare would pay $20 for a license. An individual 18 years or older who wants to obtain a medical marijuana license would need a board-certified physician’s signature and an individual under the age of 18 would need the signatures of two physicians and his or her parent or legal guardian. SQ 788 does not list specific qualifying conditions, thus giving more discretion to licensed physicians to determine wellness plans with their patients.
Under this initiative, employers, landlords, and schools are forbidden from penalizing persons for holding a medical marijuana license, unless failing to do so causes a loss of benefits under federal law or the license-holders possess or use marijuana while at work.
Individuals possessing a medical marijuana license would be authorized to consume marijuana and possess up to three ounces, six mature and six seedling marijuana plants, up to one ounce of concentrated marijuana, up to 72 ounces of edible marijuana, and up to eight ounces of marijuana in their residences. However, possessing up to 1.5 ounces of marijuana without a license but with a medical condition would be deemed a misdemeanor.
For additional information, contact NORML’s Kevin Mahmalji at: KevinM@norml.org.
NORML’s mission is to move public opinion sufficiently to legalize the responsible use of marijuana by adults, and to serve as an advocate for consumers to assure they have access to high-quality marijuana that is safe, convenient and affordable.
Source: NORML press release